Spain Within the past decade, Spain has developed into a top player in the European clinical trial network. The pharmaceutical industry has been increasing its investment commitment in the market and taking advantage of the country’s outstanding public health system. These activities are being well received by the government, so much…
Korea The South Korean medical devices market has expanded significantly in recent years; from USD 4.2 billion in 2013 to USD 5.5 billion in 2017. Production, exports and imports are all on the rise too, as the below chart shows. The Top 10 export and import destinations for Korean medtech. The…
Europe The Top Pharma Markets in Europe for 2016 according to the latest EFPIA figures. Germany leads the way, with a market size of EUR 30.815 billion, followed by France and Italy.
Europe 125 medicines for rare diseases were approved by the EMA between 2004 and 2014, of which 71 were granted orphan drug status. This chart shows the availability of 112 of these drugs across European countries. The largest number of medicines for rare diseases were in continuous use in Germany and…
Spain This map of the distribution of biotech companies throughout Spain shows that the country’s most significant biotech clusters are in Catalonia (23.3% of all biotech companies), followed by Madrid (18.7%), Valencia (10%) and the Basque Country (8.8%). The number of active biotech companies in Spain peaked in 2011 at 660 and…
Malaysia A map showing 18 of the active clinical trials sites in Malaysia in 2017. The sites are spread across the entire nation and cover a variety of therapeutic areas – including gastroenterology / hepatology, cardiology and oncology – with a cluster of activity in Kuala Lumpur. In terms of…
EUROPE The latest EFPIA data on the VAT rates applied to medicines in European countries in 2018.
Malaysia The Top 10 pharma importers in Malaysia for 2017 ranked by total revenue and market share. Pfizer holds top spot with 10.2% market share and USD 108 million in revenue, followed by MSD and Bayer. The top 10 pharma wholesalers in Malaysia for 2017 ranked by total revenue and market…
Europe The latest EFPIA data ranking European countries by the value of their pharmaceutical production. Switzerland is far and away the leader by this measurement, with EUR 46.280 billion-worth of pharma production in 2016, followed by Italy and Germany.
Spain With Spain’s economy on the road to recovery after experiencing a period of financial crisis, multinational companies are once again seeing the country as a prime investment destination. The top 20 pharmaceutical companies in Spain — combining the prescription and consumer market — in the year up to April…
Korea According to data from the Ministry of Health and Welfare, South Korea’s exports of products in the healthcare sector surged 30.9 percent in the first half from last year. Exports of drugs, medical devices, and cosmetics amounted to $7.1 billion (7.8 trillion won) in the first half, up almost 31 percent…
Europe European countries ranked by the levels of generics penetration within their domestic markets. Poland comes out on top by this measurement, with generic medicines making up a full 60.4% of market sales value, followed closely by Russia and Italy. At the other end of the scale, generics make up just…
See our Cookie Privacy Policy Here